Department of Cardiovascular Medicine, San Donato Hospital, Arezzo, Italy.
Am J Cardiol. 2013 Sep 15;112(6):782-91. doi: 10.1016/j.amjcard.2013.04.056. Epub 2013 Jun 6.
Endothelial progenitor cells (EPCs) are released from the bone marrow during cardiac ischemic events, potentially influencing vascular and myocardial repair. We assessed the clinical and angiographic correlates of EPC mobilization at the time of primary percutaneous coronary intervention in 78 patients with ST elevation myocardial infarction and the impact of both baseline and follow-up EPC levels on left ventricular (LV) remodeling. Blood samples were drawn from the aorta and the culprit coronary artery for cytofluorimetric EPC detection (CD34+CD45dimKDR+ cells, in percentage of cytofluorimetric counts). Area at risk was assessed by Bypass Angioplasty Revascularization Investigation myocardial jeopardy index, thrombotic burden as thrombus score and microvascular obstruction (MVO) as a combination of ST segment resolution and myocardial blush grade. Echocardiographic evaluation of LV remodeling was performed at 1-year follow-up in 54 patients, whereas peripheral EPC levels were reassessed in 40 patients. EPC levels during primary percutaneous coronary intervention were significantly higher in intracoronary than in aortic blood (0.043% vs 0.0006%, p <0.001). Both intracoronary and aortic EPC were related to area at risk extent, to intracoronary thrombus score (p <0.001), and inversely to MVO (p = 0.001). Peripheral EPC levels at 1-year follow-up were lower in patients with LV remodeling than in those without (0.001% [0.001 to 0.002] vs 0.003% [0.002 to 0.010]; p = 0.01) and independently predicted absence of remodeling at multivariate analysis. In conclusion, a rapid intracoronary EPC recruitment takes place in the early phases of ST elevation myocardial infarction, possibly reflecting an attempted reparative response. The extent of this mobilization seems to be correlated to the area at risk and to the amount of MVO. Persistently low levels of EPC are associated to LV remodeling.
内皮祖细胞(EPC)在心脏缺血事件期间从骨髓中释放出来,可能影响血管和心肌修复。我们评估了 78 例 ST 段抬高型心肌梗死患者在初次经皮冠状动脉介入治疗时 EPC 动员的临床和血管造影相关性,并评估了基线和随访时 EPC 水平对左心室(LV)重构的影响。从主动脉和罪犯冠状动脉采血,进行流式细胞术 EPC 检测(CD34+CD45dimKDR+细胞,以流式细胞术计数的百分比表示)。危险区面积通过旁路血管成形术血管重建调查心肌危险指数评估,血栓负荷为血栓评分,微血管阻塞(MVO)为 ST 段缓解和心肌灌注分级的组合。54 例患者在 1 年时进行 LV 重构超声心动图评估,40 例患者再次评估外周血 EPC 水平。初次经皮冠状动脉介入治疗时,冠状动脉内 EPC 水平明显高于主动脉内(0.043%比 0.0006%,p<0.001)。冠状动脉内和主动脉内 EPC 均与危险区面积相关,与冠状动脉内血栓评分相关(p<0.001),与 MVO 呈负相关(p=0.001)。1 年随访时,LV 重构患者的外周血 EPC 水平低于无重构患者(0.001%[0.001 至 0.002]比 0.003%[0.002 至 0.010];p=0.01),且在多变量分析中独立预测无重构。总之,ST 段抬高型心肌梗死早期迅速发生冠状动脉内 EPC 募集,可能反映了修复反应。这种动员的程度似乎与危险区面积和 MVO 量相关。持续低水平的 EPC 与 LV 重构相关。